Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Net Income: 2010-2024

Historic Net Income for Kura Oncology (KURA) over the last 7 years, with Dec 2024 value amounting to -$174.0 million.

  • Kura Oncology's Net Income fell 36.23% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$214.9 million, marking a year-over-year change of. This contributed to the annual value of -$174.0 million for FY2024, which is 13.99% down from last year.
  • According to the latest figures from FY2024, Kura Oncology's Net Income is -$174.0 million, which was down 13.99% from -$152.6 million recorded in FY2023.
  • In the past 5 years, Kura Oncology's Net Income ranged from a high of -$135.8 million in FY2022 and a low of -$174.0 million during FY2024.
  • For the 3-year period, Kura Oncology's Net Income averaged around -$154.2 million, with its median value being -$152.6 million (2023).
  • Data for Kura Oncology's Net Income shows a maximum YoY decreased of 13.99% (in 2024) over the last 5 years.
  • Over the past 3 years, Kura Oncology's Net Income (Yearly) stood at -$135.8 million in 2022, then dropped by 12.36% to -$152.6 million in 2023, then decreased by 13.99% to -$174.0 million in 2024.